Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3407

1.

ESTIMATION OF RADIATION DOSE IN CT VENOGRAPHY OF THE LOWER EXTREMITIES: PHANTOM EXPERIMENTS USING DIFFERENT AUTOMATIC EXPOSURE CONTROL SETTINGS AND SCAN RANGES.

Inoue Y, Itoh H, Nagahara K, Takahashi Y.

Radiat Prot Dosimetry. 2019 Dec 11. pii: ncz265. doi: 10.1093/rpd/ncz265. [Epub ahead of print]

PMID:
31822914
2.

Appetite Status After Transcatheter Aortic Valve Implantation.

Itoh H, Kaneko H.

Int Heart J. 2019;60(6):1236-1237. doi: 10.1536/ihj.19-550. No abstract available.

3.

Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study).

Ito S, Itoh H, Rakugi H, Okuda Y, Yoshimura M, Yamakawa S.

Hypertension. 2020 Jan;75(1):51-58. doi: 10.1161/HYPERTENSIONAHA.119.13569. Epub 2019 Dec 2.

PMID:
31786983
4.

Acute gastrointestinal hemorrhage in Kawasaki disease occurring before aspirin therapy.

Asada D, Taura Y, Itoh H, Tatsumi Y.

Pediatr Int. 2019 Nov;61(11):1177-1178. doi: 10.1111/ped.13989. No abstract available.

PMID:
31773846
5.

Neonatal Wnt-dependent Lgr5 positive stem cells are essential for uterine gland development.

Seishima R, Leung C, Yada S, Murad KBA, Tan LT, Hajamohideen A, Tan SH, Itoh H, Murakami K, Ishida Y, Nakamizo S, Yoshikawa Y, Wong E, Barker N.

Nat Commun. 2019 Nov 26;10(1):5378. doi: 10.1038/s41467-019-13363-3.

6.

Foxo in T Cells Regulates Thermogenic Program through Ccr4/Ccl22 Axis.

Kikuchi T, Nakae J, Kawano Y, Watanabe N, Onodera M, Itoh H.

iScience. 2019 Nov 7;22:81-96. doi: 10.1016/j.isci.2019.11.006. [Epub ahead of print]

7.

Application of Japanese guidelines for gestational weight gain to multiple pregnancy outcomes and its optimal range in 101,336 Japanese women.

Nomura K, Nagashima K, Suzuki S, Itoh H.

Sci Rep. 2019 Nov 21;9(1):17310. doi: 10.1038/s41598-019-53809-8.

8.

Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients.

Aoki T, Akiba T, Nishiyama J, Tajiri S, Hayama N, Takahashi G, Tanaka J, Sato M, Takiguchi H, Tomomatsu H, Tomomatsu K, Takihara T, Niimi K, Oguma T, Kohno M, Masuda R, Urano T, Itoh H, Kajiwara H, Nakamura N, Kunieda E, Matsumae M, Iwazaki M, Asano K.

Respir Res. 2019 Nov 21;20(1):263. doi: 10.1186/s12931-019-1235-3.

9.

Plasticity of histone modifications around Cidea and Cidec genes with secondary bile in the amelioration of developmentally-programmed hepatic steatosis.

Urmi JF, Itoh H, Muramatsu-Kato K, Kohmura-Kobayashi Y, Hariya N, Jain D, Tamura N, Uchida T, Suzuki K, Ogawa Y, Shiraki N, Mochizuki K, Kubota T, Kanayama N.

Sci Rep. 2019 Nov 19;9(1):17100. doi: 10.1038/s41598-019-52943-7.

10.

Effect of Body Weight Change on Blood Pressure in a Japanese General Population with a Body Mass Index ≥ 22 kg/m2.

Itoh H, Kaneko H, Kiriyama H, Nakanishi K, Mizuno Y, Daimon M, Morita H, Yamamichi N, Komuro I.

Int Heart J. 2019 Nov 30;60(6):1381-1386. doi: 10.1536/ihj.19-314. Epub 2019 Nov 15.

11.

Prevalence and species richness of trematode parasites only partially recovers after the 2011 Tohoku, Japan, earthquake tsunami.

Miura O, Kanaya G, Nakai S, Itoh H, Chiba S.

Int J Parasitol. 2019 Dec;49(13-14):1023-1028. doi: 10.1016/j.ijpara.2019.07.006. Epub 2019 Nov 11.

PMID:
31726059
12.

Xanthine oxidase inhibitor ameliorates postischemic renal injury in mice by promoting resynthesis of adenine nucleotides.

Fujii K, Kubo A, Miyashita K, Sato M, Hagiwara A, Inoue H, Ryuzaki M, Tamaki M, Hishiki T, Hayakawa N, Kabe Y, Itoh H, Suematsu M.

JCI Insight. 2019 Nov 14;4(22). pii: 124816. doi: 10.1172/jci.insight.124816.

13.

Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.

Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, Yamashita K, Shigaki S, Ono T, Yukioka H, Okano H, Nabeshima YI, Imai SI, Yasui M, Tsubota K, Itoh H.

Endocr J. 2019 Nov 2. doi: 10.1507/endocrj.EJ19-0313. [Epub ahead of print]

14.

Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions.

Miyamoto J, Ohue-Kitano R, Mukouyama H, Nishida A, Watanabe K, Igarashi M, Irie J, Tsujimoto G, Satoh-Asahara N, Itoh H, Kimura I.

Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23813-23821. doi: 10.1073/pnas.1912573116. Epub 2019 Nov 4.

15.

Association between olfactory sulcus morphology and olfactory functioning in schizophrenia and psychosis high-risk status.

Takahashi T, Nakamura M, Sasabayashi D, Nishikawa Y, Takayanagi Y, Furuichi A, Kido M, Mizukami Y, Nishiyama S, Higuchi Y, Tateno T, Itoh H, Noguchi K, Masaoka Y, Suzuki M.

Heliyon. 2019 Oct 10;5(10):e02642. doi: 10.1016/j.heliyon.2019.e02642. eCollection 2019 Oct.

16.

Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort.

Morisaki M, Kurihara I, Itoh H, Naruse M, Takeda Y, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Sone M, Tsuiki M, Shibata H, Kawashima J, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Suzuki T; JPAS Study Group.

J Endocr Soc. 2019 Aug 22;3(11):2012-2022. doi: 10.1210/js.2019-00295. eCollection 2019 Nov 1.

17.

Host-symbiont specificity determined by microbe-microbe competition in an insect gut.

Itoh H, Jang S, Takeshita K, Ohbayashi T, Ohnishi N, Meng XY, Mitani Y, Kikuchi Y.

Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22673-22682. doi: 10.1073/pnas.1912397116. Epub 2019 Oct 21.

PMID:
31636183
19.

Pharmacokinetic and toxicodynamic evaluation of 5-fluorouracil administration after major hepatectomy in a rat model.

Tada K, Iwashita Y, Shiraiwa K, Uchida H, Oshima Y, Sato Y, Nakanuma H, Hirashita T, Masuda T, Endo Y, Takeuchi Y, Ohta M, Itoh H, Inomata M.

Cancer Chemother Pharmacol. 2019 Oct 11. doi: 10.1007/s00280-019-03969-1. [Epub ahead of print]

PMID:
31605153
20.

Feature visualization of Raman spectrum analysis with deep convolutional neural network.

Fukuhara M, Fujiwara K, Maruyama Y, Itoh H.

Anal Chim Acta. 2019 Dec 9;1087:11-19. doi: 10.1016/j.aca.2019.08.064. Epub 2019 Aug 29.

PMID:
31585558
21.

Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension.

Rakugi H, Ito S, Itoh H, Okuda Y, Yamakawa S.

Hypertens Res. 2019 Dec;42(12):1932-1941. doi: 10.1038/s41440-019-0314-7. Epub 2019 Sep 25.

PMID:
31554937
22.

Biological Effects of a Simplified Synthetic Analogue of Ion-Channel-Forming Polytheonamide B on Plasma Membrane and Lysosomes.

Xue YW, Hayata A, Itoh H, Inoue M.

Chemistry. 2019 Nov 27;25(66):15198-15204. doi: 10.1002/chem.201903974. Epub 2019 Oct 25.

PMID:
31549755
23.

Artificial Intelligence-assisted System Improves Endoscopic Identification of Colorectal Neoplasms.

Kudo SE, Misawa M, Mori Y, Hotta K, Ohtsuka K, Ikematsu H, Saito Y, Takeda K, Nakamura H, Ichimasa K, Ishigaki T, Toyoshima N, Kudo T, Hayashi T, Wakamura K, Baba T, Fumio I, Inoue H, Itoh H, Oda M, Mori K.

Clin Gastroenterol Hepatol. 2019 Sep 13. pii: S1542-3565(19)30997-8. doi: 10.1016/j.cgh.2019.09.009. [Epub ahead of print]

PMID:
31525512
24.

Difference in Z scores of placental weight and fetal/placental weight ratio by mode of delivery.

Matsuda Y, Itoh T, Okada E, Sasaki K, Itoh H, Kanayama N.

J Obstet Gynaecol Res. 2019 Dec;45(12):2377-2385. doi: 10.1111/jog.14117. Epub 2019 Sep 15.

PMID:
31523912
25.

Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetes.

Watanabe Y, Saisho Y, Inaishi J, Kou K, Yamauchi A, Kanazawa Y, Okubo Y, Tokui M, Imai T, Murakami R, Tsuchiya T, Sasaki H, Masaoka T, Irie J, Meguro S, Itoh H; Twin-exenatide Study Group.

J Diabetes Investig. 2019 Sep 13. doi: 10.1111/jdi.13146. [Epub ahead of print]

26.

Effects of a Physical Therapist Led Workplace Personal-Fitness Management Program for Manufacturing Industry Workers: A Randomized Controlled Trial.

Matsugaki R, Sakata M, Itoh H, Matsushima Y, Saeki S.

J Occup Environ Med. 2019 Nov;61(11):e445-e451. doi: 10.1097/JOM.0000000000001712.

PMID:
31517759
27.

Low birth weight is associated with decline in renal function in Japanese male and female adolescents.

Murai-Takeda A, Kanda T, Azegami T, Hirose H, Inokuchi M, Tokuyama H, Wakino S, Tokumura M, Kawabe H, Mori M, Itoh H.

Clin Exp Nephrol. 2019 Dec;23(12):1364-1372. doi: 10.1007/s10157-019-01784-9. Epub 2019 Sep 7.

PMID:
31494799
28.

Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids.

Miyamoto J, Igarashi M, Watanabe K, Karaki SI, Mukouyama H, Kishino S, Li X, Ichimura A, Irie J, Sugimoto Y, Mizutani T, Sugawara T, Miki T, Ogawa J, Drucker DJ, Arita M, Itoh H, Kimura I.

Nat Commun. 2019 Sep 5;10(1):4007. doi: 10.1038/s41467-019-11978-0.

29.

Relationships between endogenous CYP3A markers and plasma amlodipine exposure and metabolism in early postpartum and non-peripartum women with hypertension.

Taguchi R, Naito T, Kubono N, Ogawa N, Itoh H, Kawakami J.

Pregnancy Hypertens. 2019 Jul;17:209-215. doi: 10.1016/j.preghy.2019.07.002. Epub 2019 Jul 4.

PMID:
31487643
30.

Vaccine Development against the Renin-Angiotensin System for the Treatment of Hypertension.

Azegami T, Itoh H.

Int J Hypertens. 2019 Aug 14;2019:9218531. doi: 10.1155/2019/9218531. eCollection 2019. Review.

31.

Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsuiki M, Naruse M; JPAS Study Group.

J Hum Hypertens. 2019 Aug 28. doi: 10.1038/s41371-019-0229-4. [Epub ahead of print]

PMID:
31462725
32.

Withdrawal of the 1999 JSOG recommendation of weight gain restriction during pregnancy (Commentary of the JSOG Perinatal Committee).

Itoh H, Itakura A, Kanayama N, Ikeda T.

J Obstet Gynaecol Res. 2019 Nov;45(11):2302. doi: 10.1111/jog.14080. Epub 2019 Aug 27. No abstract available.

PMID:
31456287
33.

Correction to: Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study.

Kiriyama H, Kaneko H, Itoh H, Yoshida Y, Nakanishi K, Mizuno Y, Daimon M, Morita H, Yatomi Y, Komuro I.

J Nephrol. 2019 Oct;32(5):843-846. doi: 10.1007/s40620-019-00635-w.

PMID:
31429048
34.

Effects of work schedule and period of exposure on changes in urinary chromium and nickel excretion among rotating shift workers in a stainless-steel plant.

Itoh H, Wang RS, Maki S, Niu Q, Shang H, Su Y, Weng Z, Saito H, Miura N, Takahashi M.

Chronobiol Int. 2019 Oct;36(10):1439-1446. doi: 10.1080/07420528.2019.1645159. Epub 2019 Aug 1.

PMID:
31368363
35.

Treatment preference for weekly versus daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: outcomes from the TRINITY trial.

Meguro S, Matsui S, Itoh H.

Curr Med Res Opin. 2019 Dec;35(12):2071-2078. doi: 10.1080/03007995.2019.1651130. Epub 2019 Aug 22.

PMID:
31366262
36.

Successful determination of nilotinib dosage by therapeutic drug monitoring in a patient with chronic myeloid leukemia developing hepatic dysfunction: A case report.

Nakahara R, Sumimoto T, Ogata M, Sato Y, Itoh H.

Clin Case Rep. 2019 Jun 14;7(7):1419-1421. doi: 10.1002/ccr3.2191. eCollection 2019 Jul.

37.

Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.

Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M, Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, Naruse M; JPAS/JRAS Study Group.

Hypertension. 2019 Sep;74(3):630-638. doi: 10.1161/HYPERTENSIONAHA.119.13131. Epub 2019 Jul 22.

PMID:
31327258
38.

Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M.

Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0047.R2. doi: 10.1530/EJE-19-0047. [Epub ahead of print]

PMID:
31319380
39.

Development of a high-throughput strategy for discovery of potent analogues of antibiotic lysocin E.

Itoh H, Tokumoto K, Kaji T, Paudel A, Panthee S, Hamamoto H, Sekimizu K, Inoue M.

Nat Commun. 2019 Jul 5;10(1):2992. doi: 10.1038/s41467-019-10754-4.

40.

Cost-Effectiveness of Cardiac Rehabilitation in Patients with Coronary Artery Disease: A Meta-Analysis.

Takura T, Ebata-Kogure N, Goto Y, Kohzuki M, Nagayama M, Oikawa K, Koyama T, Itoh H.

Cardiol Res Pract. 2019 Jun 4;2019:1840894. doi: 10.1155/2019/1840894. eCollection 2019. Review.

41.

Greeting Messages from President of Japanese Society of Hypertension (JSH) The challenge of JSH: moonshot for "Conquest of hypertension in Japan".

Itoh H.

Hypertens Res. 2019 Jul;42(7):925-927. doi: 10.1038/s41440-019-0279-6. Epub 2019 Jul 5. No abstract available.

PMID:
31273348
42.

National burden of the pharmaceutical cost of wet compresses and its cost predictors: nationwide cross-sectional study in Japan.

Itoh H, Saito T, Nojiri S, Hiratsuka Y, Yokoyama K.

Health Econ Rev. 2019 Jun 29;9(1):20. doi: 10.1186/s13561-019-0238-6.

43.

Comparative genome-wide analysis of gastric adenocarcinomas with hyperplastic polyp components.

Takayama Y, Ono Y, Mizukami Y, Itoh H, Nakajima N, Arai H, Tanaka S, Nobusawa S, Yokoo H, Onozato Y.

Virchows Arch. 2019 Sep;475(3):383-389. doi: 10.1007/s00428-019-02592-y. Epub 2019 Jun 28.

PMID:
31250201
44.

DNA Damage Repair and DNA Methylation in the Kidney.

Hayashi K, Hishikawa A, Itoh H.

Am J Nephrol. 2019;50(2):81-91. doi: 10.1159/000501356. Epub 2019 Jun 26. Review.

45.

Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study.

Itoh H, Ito S, Rakugi H, Okuda Y, Nishioka S.

Hypertens Res. 2019 Oct;42(10):1572-1581. doi: 10.1038/s41440-019-0270-2. Epub 2019 Jun 25.

PMID:
31239535
46.

Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation.

Ueshima S, Hira D, Tomitsuka C, Nomura M, Kimura Y, Yamane T, Tabuchi Y, Ozawa T, Itoh H, Horie M, Terada T, Katsura T.

AAPS J. 2019 Jun 24;21(5):80. doi: 10.1208/s12248-019-0353-7.

PMID:
31236790
47.

Hypertension as a Metabolic Disorder and the Novel Role of the Gut.

Tanaka M, Itoh H.

Curr Hypertens Rep. 2019 Jun 24;21(8):63. doi: 10.1007/s11906-019-0964-5. Review.

48.

Full solid-phase total synthesis of macrocyclic natural peptides using four-dimensionally orthogonal protective groups.

Itoh H, Inoue M.

Org Biomol Chem. 2019 Jul 21;17(27):6519-6527. doi: 10.1039/c9ob01130g. Epub 2019 Jun 24.

PMID:
31232404
49.

Effect of Metabolically Healthy Obesity on the Development of Carotid Plaque in the General Population: A Community-Based Cohort Study.

Itoh H, Kaneko H, Kiriyama H, Yoshida Y, Nakanishi K, Mizuno Y, Daimon M, Morita H, Yatomi Y, Yamamichi N, Komuro I.

J Atheroscler Thromb. 2019 Jun 22. doi: 10.5551/jat.48728. [Epub ahead of print]

50.

Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment-Two Case Reports.

Ryuzaki M, Tokuyama H, Uchiyama K, Nakaya H, Hasegawa K, Miyashita K, Konishi K, Hashiguchi A, Wakino S, Itoh H.

Clin Med Insights Case Rep. 2019 Jun 13;12:1179547619853647. doi: 10.1177/1179547619853647. eCollection 2019.

Supplemental Content

Support Center